Primeadine
Primeadine

Start-up Sentai wins UK independent living grant

Machine-learning smart device uses AI to promote independence and safety.

A British technology start-up focused on helping the elderly live more independently in their own home has received financial backing from the UK Government. Accelerated by the coronavirus crisis and rising loneliness amongst the elderly, Sentai, a portable smart device using AI and Augmented Voice Technology to monitor and support older people, has received a grant from Innovate UK, the UK’s innovation agency.

Longevity.Technology:  This device concept hits the market at a time when it is estimated 1.4 million people aged 50 and over in England alone suffer from loneliness. And with the number of people in Europe aged 80 and over expected to more than double by 2070, from 29 million to over 60 million, the need to support and monitor the elderly will be crucial in a post-pandemic world.

Thanks to advancements in machine-learning capabilities, Sentai can provide a contextual experience with the user, meaning conversations feel natural rather than robotic or one way. For example, it can detect the mood of a person from their voice and centre responses around that, whilst providing timely prompts around important things such as medication.

The idea is to offer a small, discreet, personal task force to deal with the day-to-day care needs of the elderly, whilst keeping them connected to their loved ones and community. The caregiver can stay connected via a smart app, with daily performance logs and push notifications enabling them to get peace of mind.

Phil Marshman, Sentai’s CEO and founder, said: “We’re delighted to see the Government backing us under the Sustainable Innovation Fund, as it serves to underline how much our product is needed. With winter fast approaching and another national lockdown underway, loneliness is only set to rise further, and we want to be able to ensure our loved ones are monitored and supported when we can’t physically be with them.”

 


 

“We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

 


 

He continued: “We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

First Longevity

Also, equipped with sensors, Sentai monitors movements and can call for help if someone falls, and can remind them to take medication throughout the day as needed.

Dr Ian Campbell, Executive Chair of Innovate UK, said: “In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy.

“Sentai, along with every initiative Innovate UK has supported through this fund, is an important step forward in driving sustainable economic development. Each one is also helping to realise the ambitions of hard-working people.”

Innovate UK is investing up to £191million to fund research and development projects with the aim of helping all sectors of the UK rebuild after the effects of COVID-19, the fund is supporting 1,103 projects and 1,189 UK businesses, totalling over £130million in aid.

We recently reported how the UK’s Industrial Strategy Challenge Fund has developed a programme to promote new healthy aging solutions. The Healthy Aging Investment Accelerator is a five-year initiative to support smaller tech companies who are working to combat health issues related to the aging process, and is part of the UK Government’s commitment to developing the role technology can play in improving healthcare.

To further help get the device into the homes of people who need it, Sentai is preparing to launch a Kickstarter campaign to raise funds for the next stage of its development – the success of which will see its pioneering technology brought to mass market. Details of the Kickstarter are due to be announced imminently.

First Longevity
Image courtesy of Sentai
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Primeadine
whoop
Primeadine
whoop

Latest articles

Neurotech2020 – a clear head for neurotech, research and investment

Tomorrow's dreams today ... well, next week – it's Neurotech2020. Neurotech2020 – the digital congress for neurotechnology innovation and growth – is coming to (your...

Biotech Elevian announces $15m equity financing

The anti-aging company looks to the clinic with Prime Movers Lab leading the round. Massachusets-based Elevian announced this week that it had closed $15 million equity...

eGenesis advances xenotransplantation research

Reducing waiting lists and treating diabetes – eGenesis progresses xeno without the paradox. Recently we covered eGenesis' progress in its xenotransplantation research, as it attempts...

Review: WHOOP fitness tracker

We trialled this beautifully-understated fitness/sleep tracking device to see if it would make us whoop with joy or holler for something else.   GO LONG    GO...